PharmaShots | Incisive News in 3 Shots

Subscribe Now

Moderate-to-Severe Plaque Psoriasis

Sun Pharma's Ilumya Receives Australian Therapeutic Goods Administration (TGA) Approval for the Treatment of Moderate-to-Severe Plaque Psoriasis

Sun Pharma's Ilumya Receives Australian Therapeutic Goods Administration (TGA) Approval for the Treatment of Moderate-to-Severe Pl...

September 24, 2018

Celgene Reports Improvement in Patients with Moderate-to-Severe Plaque Psoriasis with OTEZLA in P-III ESTEEM trial

Celgene Reports Improvement in Patients with Moderate-to-Severe Plaque Psoriasis with OTEZLA in P-III ESTEEM trial

September 13, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us